Pyrogen Testing Market Analysis and Forecast Report, 2018 to 2025
by Susan Hill Business ConsultantThe global pyrogen testing market is expected to reach a value of
USD 1.9 billion by 2025, according to a new report by Grand View Research, Inc.
Increasing demand for therapeutic drugs including pharmaceuticals,
biopharmaceuticals, and biologics is the major factor that propels growth of
the market during forecast period. Pyrogen is a toxic molecular substance that
causes fever if induced in animal or human body. Pyrogen testing is used by
pharmaceutical, biopharmaceuticals, biotechnology, and medical devices
companies to confirm the absence of pyrogen. Thus, the companies use various
methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of
products.
Increasing prevalence of chronic diseases, is another foremost factor supporting the growth of the pyrogen testing market. The prevalence of chronic diseases is very high in developed countries and is growing at high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise leads to occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases. Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.
Further key findings from the study suggest:
- Consumables was the largest revenue grossing segment of the pyrogen
testing market in 2016, owing to the large application of pyrogen testing
kits and reagents along with its repetitive purchase.
- Instruments segment accounted for the remarkable share in the market
in 2016 and is also expected to showcase significant growth during
forecast period, owing to rising demand for pharmaceutical, biologics, and medical
devices for treatment and diagnosis.
- The pharmaceutical and biotechnology companies segment dominated the
pyrogen testing market in terms of revenue in 2016, due to the large
production of therapeutic drugs and growing investment in R&D by
companies for drug development.
- North America is the leading regional market and accounted for the
largest revenue share in 2016 primarily due to the existence of large
number of healthcare companies including pharmaceuticals and medical
devices in this region.
- The Asia Pacific region is anticipated to be the fastest growing
market during the study period. The growing prevalence rate of chronic
diseases in the Asian countries including India and China, is a major
factor contributing to the expansion of market in this region.
- Some major players serving this vertical include Charles River
Laboratories, Inc.; Ellab A/S; Merck KGaA; GenScript; Hyglos GmbH; Lonza;
Thermo Fisher Scientific, Inc.; Associates of Cape Cod, Inc.; and Pyrostar
Grand View Research has segmented the pyrogen
testing market on the basis of product, test type, end-use, and region:
Pyrogen
Testing Product Outlook (Revenue, USD Million; 2014 - 2025)
- Consumables
- Instruments
- Services
Pyrogen
Testing Test Type Outlook (Revenue, USD Million; 2014 - 2025)
- LAL test
- Chromogenic test
- Turbidimetric test
- Gel clot test
- In vitro pyrogen
test
- Rabbit test
Pyrogen
Testing End-Use Outlook (Revenue, USD Million; 2014 - 2025)
- Pharmaceutical and biotechnology companies
- Medical devices companies
- Others
Pyrogen
Testing Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
Access full research report on global pyrogen testing market:
http://www.grandviewresearch.com/industry-analysis/pyrogen-testing-market
Sponsor Ads
Created on Jul 3rd 2019 08:57. Viewed 323 times.